Arunjyoti Bio Ventures Ltd

Arunjyoti Bio Ventures Ltd (ABVL) is a micro-cap Financial Services company valued at ₹79 crore operating in Other Financial Services on the NSE and BSE.

Recent price move

Arunjyoti Bio Ventures Ltd last traded at ₹4.22, modestly down 1.40% on the day.

Recent developments

On 2026-09-30, the company reported a net loss of ₹5 crore for its latest financial year, which marks a widening loss compared to the prior year. In the latest quarter ended 2026-06-30, net profit fell to ₹1 crore, down from ₹2 crore in the same quarter a year earlier.

Financial performance

The company's business has seen revenue grow at 151.7% annually over the past three years, but annual net profit turned from a ₹2 crore loss to a ₹5 crore loss, widening the loss. The latest quarter showed revenue fell 5.9% year-on-year while net profit dropped 74.2%, worsening the margin from -6.5% to -16.3%.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 3.00 times book value.

Things to watch

The company reported a net loss of ₹5 crore in its latest financial year, which is a widening loss compared to the prior year. The net profit margin has deteriorated to -16.3%, down 9.8 percentage points from the previous year. The stock is 62.6% below its 52-week high.

Where it stands

The company ended its latest financial year with a net loss of ₹5 crore, a widening loss from the prior year. The latest quarter showed a sharp drop in net profit, falling 74.2% year-on-year. The stock is 62.6% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.